Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  PEG-interferon alfa-2a
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Phase: Phase IV
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: KMUH-IRB-960043, NCT00834860
Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: ML17840, NCT00204529
Imatinib or Nilotinib With Pegylated Interferon-a2b in Chronic Myeloid Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2006.128, HUM9600, NCT00573378
Pegasys® in Patients With Myeloproliferative Diseases
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: DM03-0109, NCI-2012-01474, NCT00452023
Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: PVN1, NCT00241241
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 months to 21 years
Sponsor: NCI, NIH WGMCC
Protocol IDs: 050232, 05-C-0232, NCI-P6670, CDR0000448811, NCI-05-C-0232, NCT00253474
Start Over